Загрузка...
Triple action Pt(iv) derivatives of cisplatin: a new class of potent anticancer agents that overcome resistance
A series of triple action Pt(iv) prodrugs was designed to test the hypothesis that multi-action compounds, where each bioactive moiety intervenes in several cellular processes, might be more effective than a single agent at killing cancer cells. In particular, “triple action” Pt(iv) derivatives of c...
Сохранить в:
| Опубликовано в: : | Chem Sci |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Royal Society of Chemistry
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5944384/ https://ncbi.nlm.nih.gov/pubmed/29780561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/c8sc00428e |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|